DNA-RNA complementation on silicon wafer for thyroid cancer determination

Area of Science:

• Biomedical Engineering
• Molecular Diagnostics
• Oncology

Background:

• Early diagnosis of thyroid tumors significantly improves treatment outcomes.
• MicroRNAs (miRNAs) are emerging as critical biomarkers for various cancers, including thyroid.
• Sensitive and specific detection methods are needed for accurate miRNA quantification in clinical settings.

Purpose of the Study:

• To develop and validate a novel biosensor for the detection and quantification of miR-222.
• To assess the potential of miR-222 as a diagnostic marker for thyroid tumor progression.
• To establish a highly sensitive method for miRNA detection using interdigitated electrodes.

Main Methods:

• Fabrication of an amine-functionalized interdigitated electrode (IDE) sensor on a silicon wafer.
• Immobilization of carboxylated-DNA probes for capturing specific target sequences.
• Detection of miR-222 through DNA-target RNA complementation and measurement of current responses.

Main Results:

• Achieved a low detection limit of 1 fM for miR-222 with high sensitivity.
• Demonstrated specific target validation through control experiments with noncomplementary sequences.
• Observed a direct correlation between current response and target RNA concentration.

Conclusions:

• The developed IDE sensor offers a highly sensitive and specific platform for miR-222 detection.
• miR-222 shows promise as a valuable biomarker for the diagnosis and monitoring of thyroid tumor progression.
• This biosensor technology can aid in the early diagnosis of thyroid atypia, potentially improving patient management.